NCT06650878

Brief Summary

This study aims to evaluate whether a surgical technique (Desarda) is superior to the commonly used surgical technique (Lichtenstein) in inguinal hernia repair concerning the occurrence of postoperative complications. The Lichtenstein technique involves the use of a mesh, while the Desarda technique does not.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
478

participants targeted

Target at P75+ for not_applicable

Timeline
55mo left

Started Mar 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Mar 2025Dec 2030

First Submitted

Initial submission to the registry

October 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 21, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

March 26, 2025

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

June 24, 2025

Status Verified

June 1, 2025

Enrollment Period

2.7 years

First QC Date

October 18, 2024

Last Update Submit

June 18, 2025

Conditions

Keywords

Inguinal Hernialichtenstein techniquedesarda technique

Outcome Measures

Primary Outcomes (1)

  • Rate of Participants with Post-surgery Complications

    Any of the following complications: ● Sensation of a foreign body that persists beyond 3 months after surgery, self-reported by the participant ● Seroma within the first 30 days after surgery, verified through physical examination by a surgeon ● Hematoma within the first 30 days after surgery, verified through physical examination by a surgeon ● Infection at the surgical site within the first 30 days after surgery, verified by a surgeon ● Severe postoperative pain (7 or higher on the visual analog scale \[VAS\]) within the first 30 days after surgery, self-reported by the participant ● Chronic postoperative pain (persisting more than three months after surgery), self-reported by the participant ● Persistent loss of skin sensitivity beyond 30 days after surgery, self-reported by the participant ● Limitation of normal activities at home, outside the home, or at work beyond 3 months after surgery, self-reported by the participant

    3 months

Study Arms (2)

Desarda Technique

EXPERIMENTAL

Patients asigned to this arm will be treated with Desarda Technique

Procedure: Desarda

Lichtenstein Technique

ACTIVE COMPARATOR

Patients asigned to this arm will be treated with Lichtenstein Technique

Procedure: Lichtenstein

Interventions

DesardaPROCEDURE

This technique prevent from using a mesh to surgical repair of a inguinal hernia

Desarda Technique
LichtensteinPROCEDURE

This technique implies using a mesh to surgical repair of a inguinal hernia

Lichtenstein Technique

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with primary inguinal hernia.
  • Body mass index below 31
  • Indication for inguinal hernia repair via anterior approach, either as outpatient surgery (CMA) or elective admission.
  • Legal capacity to provide informed consent.

You may not qualify if:

  • Patients with a weak, thin, or divided external oblique aponeurosis.
  • Participants diagnosed with any of the following conditions:
  • Ongoing oncological disease
  • Cirrhotic patients classified as Child B or higher
  • Women who have previously undergone a cesarean section
  • Cognitive or affective conditions that limit the ability to cooperate with the study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CSAPG

Sant Pere de Ribes, Barcelona, 08810, Spain

RECRUITING

MeSH Terms

Conditions

Hernia, Inguinal

Condition Hierarchy (Ancestors)

Hernia, AbdominalHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Javier Errando, MD

    CSAPG

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Javier Errando, MD

CONTACT

Noemi Casaponsa

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 18, 2024

First Posted

October 21, 2024

Study Start

March 26, 2025

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2030

Last Updated

June 24, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After publication of main results of the study.
Access Criteria
IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.

Locations